Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 5, 2003, Pages 1041-1048

  Pierzchalska, Małgorzata ^a   Szabó, Zsuzsanna ^b   Sanak, Marek ^a   Soja, Jerzy ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

Aspirin induced asthma; Asthma; Cyclooxygenase 1; Cyclooxygenase 2; Human bronchial fibroblasts; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; INDOMETACIN; ISOENZYME; MEMBRANE PROTEIN; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; LUNG FIBROBLAST; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CHEMICALLY INDUCED DISORDER; FIBROBLAST; METABOLISM; MIDDLE AGED;

ADULT; AGED; ASPIRIN; ASTHMA; BRONCHI; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; FIBROBLASTS; HUMANS; INDOMETHACIN; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0037738455     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1491     Document Type: Article

References (38)

1. Chetta A, Forest A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997:111:852-7.
2. Holgate ST. The epidemic of allergy and asthma. Nature 1999:402:B2-4.
3. Davies D. The bronchial epithelium: translating gone and environment interaction in asthma. Curr Opin Allergy Immunol 2001:1:67-71.
4. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM. Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000:105:193-204.
5. Leff AR. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Thorax 2000;55:S32-7.
6. Szczeklik A, Sanak M. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitor. Clin Exp Allergy 2002:32:339-42.
7. 2 as a mediator of allergic asthma. Science 2000:287:2013-7.
8. 2. Lancet 1995;345:436-8.
9. Vally H, Taylor ML. Thompson PJ. The presence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;57:569-74.
10. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
11. Kowalski ML, Pawliczak R, Woźniak J, Siuda K, Poniatowska M, Iwaszkiewicz J, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161:391-8.
12. Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999;160:291-6.
13. Dubé J, Chakir J, Laviolette M, Saint MS, Boutet M, Desrochers C, et al. In vitro procollagen synthesis and proliferative phenotype of bronchial fibroblasts from normal and asthmatic subjects. Lab Invest 1998;78:297-307.
14. 2 production in normal and fibrotic lung fibroblasts. Am J Respir Cell Mol Biol 1999;22:628-34.
15. Niżankowska E, Bestyńska-Krypel A, Ćmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863-9.
16. Diaz A, Chepenik KP, Korn JH. Reginato AM. Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1β, tumor necrosis factor-α and transforming growth factor-β1 in human lung fibroblasts. Exp Cell Res 1998:241:222-9.
17. Noguchi K, Shitashige M, Yanai M, Morita I. Nishihara T, Murota S. Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides. Inflammation 1996;20:555-68.
18. Meade EA, Smith WL, David L, DeWitt S. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
19. 2 production. J Biol Chem 1989;264:11554-7.
20. Shindo N, Saito T, Murayama K. Rapid quantification of 11 prostanoids by combined capillary column gas chromatography and negative ion chemical ionization mass spectrometry: application to prostanoids released from normal human embryonic lung fibroblasts WI38 in a culture medium. Biomed Environ Mass Spectrom 1988;15:25-32.
21. Pang L, Pitt A, Petkova D. Knox AJ. The COX-1/COX-2 balance in asthma. Clin Exp Allergy 1998;28:1050-8.
22. Szczeklik A, Mastalerz L, Niżankowska E, Ćmiel A. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996;153:567-71.
23. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153:572-5.
24. Pavord IA, Ward R, Woltmann G, Wardlaw AJ. Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999:160:1905-9.
25. 2 and to express cyclooxygenase-2. J Clin Invest 1995:95:1861-8.
26. Johnson PR, Roth M, Tamm M. Hughes M. Ge Q, King G. et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474-7.
27. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142:126-32.
28. Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH. Barnes PJ. Induction of cyclooxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997;120:910-6.
29. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000;275:32783-92.
30. 2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000;275:32775-82.
31. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M. Jakobsson PJ, Crofford LJ. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 2001;167:469-74.
32. Wenzel SE, Westcott JY, Smith H, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. Am Rev Respir Dis 1989;139:450-7.
33. Szczeklik A, Sładek K, Dworski R, Niżankowska E. Soja J, Sheller J. et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996:154:1608-14.
34. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990;3:588-93.
35. Sousa AR, Pfister R, Christie PE. Lane SJ, Nasser SM, Schmitz-Schumann M, et al. Enhanced expression of cyclooxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthmatics. Thorax 1997;52:950-5.
36. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
37. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
38. Szczeklik A, Niżankowska E, Bochenek G, Nagraba K, Mejza F, Świerczyńska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-25.